football

Manchester United could complete transfer hijack as 'Ajax medical mysteriously postponed'


Manchester United have been credited with an interest in Nordsjaelland wonderkid Kamaldeen Sulemana and a late move from the Red Devils cannot be ruled out after the player’s medical with Ajax was postponed. There has been huge intrigue surrounding the 19-year-old in recent weeks and it’s believed that United are one of the teams who have been tracking his progress in Denmark.

Yet despite that, Ajax moved to the front of the queue by offering up to £12million.

At the end of May, Sulemana confirmed that the Eredivisie champions had presented a formal offer.

“I know there is a bid from Ajax. And that’s what I can say,” he told B.T.

“Unfortunately, I can not answer further questions, because I can not go into deeper details. But there has been a bid.”

JUST IN: Man Utd make breakthrough in Jadon Sancho negotiations with ‘£80m transfer now agreed’

Ajax have been here before. They had agreed a deal with Fluminense to sign Richarlison in 2017 before Watford hijacked the transfer.

“That could be time-wasting. I’m afraid that Ajax must fear a Richarlison,” Verweij added.

“It will probably be much more interesting for that agent to go to Manchester United with Sulemana. The commissions in England are even higher than at Ajax, but I don’t know whether that is also in the player’s interest.”

Sulemana would like to play regularly, meaning Ajax would undoubtedly be the best place for his development, particularly if United are the other club at the table.

The Dutch giants are also working on a number of other deals including the signing of Steven Berghuis.

United are already stacking with options out wide and they could be set to add Jadon Sancho to their ranks this summer.

The young Ghanaian prospect has dazzled in the Danish Superliga and scored 10 times in 29 matches last term, as he now looks set to earn a move…





READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more